These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8472524)

  • 1. [The behavior of the fibrinogen polymerization curve in hypercholesterolemic subjects].
    Alessandri C; Bucci A; Basili S; Pacillo L; Ricci G
    Clin Ter; 1993 Feb; 142(2):115-21. PubMed ID: 8472524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fibrinogen and atherothrombosis: vulnerable plaque or vulnerable patient?].
    Jaeger BR; Labarrere CA
    Herz; 2003 Sep; 28(6):530-8. PubMed ID: 14569394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinogen levels in hypercholesterolemic smokers and non-smokers in relation to age and gender.
    Schuitemaker GE; Dinant GJ; van der Pol GA; van Wersch JW
    Clin Exp Med; 2004 Apr; 3(4):231-5. PubMed ID: 15103514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma fibrinogen and its correlates in adult Saudi population.
    Alam AA; Mitwalli AH; Al-Wakeel JS; Chaudhary AR; Zebaid MA
    Saudi Med J; 2004 Nov; 25(11):1593-602. PubMed ID: 15573185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fibrinogen as an independent cardiovascular risk factor and the question of treatment with fibrinogen-lowering drugs].
    Boda Z
    Orv Hetil; 1997 Sep; 138(39):2455-60. PubMed ID: 9380384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor VII and fibrinogen levels examined by age, sex, and other atherosclerotic risk factors in a Japanese population. The Jichi Medical School Cohort Study.
    Ishikawa S; Kario K; Nago N; Kayaba K; Hiraoka J; Matsuo H; Goto T; Miyamoto T; Tsutsumi A; Nakamura Y; Shimada K; Inoue K; Igarashi M
    Thromb Haemost; 1997 May; 77(5):890-3. PubMed ID: 9184398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term (18-month) efficacy of atorvastatin therapy in type 2 diabetics at cardiovascular risk.
    Velussi M
    Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):29-35. PubMed ID: 12125227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks.
    Otto C; Ritter MM; Richter WO; Minkenberg R; Schwandt P
    Metabolism; 2001 Feb; 50(2):166-70. PubMed ID: 11229424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fresh israeli jaffa sweetie juice consumption improves lipid metabolism and increases antioxidant capacity in hypercholesterolemic patients suffering from coronary artery disease: studies in vitro and in humans and positive changes in albumin and fibrinogen fractions.
    Gorinstein S; Caspi A; Libman I; Katrich E; Lerner HT; Trakhtenberg S
    J Agric Food Chem; 2004 Aug; 52(16):5215-22. PubMed ID: 15291499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in plasma cholesterol levels in the atherosclerosis risk in communities (ARIC) study.
    Szklo M; Chambless LE; Folsom AR; Gotto A; Nieto FJ; Patsch W; Shimakawa T; Sorlie P; Wijnberg L
    Prev Med; 2000 Mar; 30(3):252-9. PubMed ID: 10684749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenic and coagulation-fibrinolysis factors in non Hodgkin's lymphoma.
    Wróbel T; Poreba M; Mazur G; Poreba R; Pyszel A; Beck B; Steinmetz-Beck A; Andrzejak R; Kuliczkowski K
    Neoplasma; 2006; 53(3):253-8. PubMed ID: 16652197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of rosiglitazone on novel atherosclerotic risk factors in patients with type 2 diabetes mellitus and hypertension. An open-label observational study.
    Sarafidis PA; Lasaridis AN; Nilsson PM; Mouslech TF; Hitoglou-Makedou AD; Stafylas PC; Kazakos KA; Yovos JG; Tourkantonis AA
    Metabolism; 2005 Sep; 54(9):1236-42. PubMed ID: 16125536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated plasma fibrinogen levels in patients with essential hypertension are related to vascular complications.
    Lechi C; Gaino S; Zuliani V; Tommasoli RM; Faccini G; Fasson R; Arcaro G; Lechi A; Minuz P
    Int Angiol; 2003 Mar; 22(1):72-8. PubMed ID: 12771860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risk factors in obese women and their first-degree relatives.
    Saraç F; Ozgen AG; Yilmaz C; Tüzün M
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):371-7. PubMed ID: 18065331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between isolated hypercholesterolemia, isolated hypertriglyceridemia and coronary artery disease in south Indian type 2 diabetic patients.
    Rajmohan L; Deepa R; Mohan A; Mohan V
    Indian Heart J; 2000; 52(4):400-6. PubMed ID: 11084779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating ICAM-1 and VCAM-1 in peripheral artery disease and hypercholesterolaemia: relationship to the location of atherosclerotic disease, smoking, and in the prediction of adverse events.
    Blann AD; Seigneur M; Steiner M; Miller JP; McCollum CN
    Thromb Haemost; 1998 Jun; 79(6):1080-5. PubMed ID: 9657427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atorvastatin reduces fibrinogen levels in patients with severe hypercholesterolemia: additional evidence to support the anti-inflammatory effects of statins.
    Leibovitz E; Hazanov N; Frieman A; Elly I; Gavish D
    Isr Med Assoc J; 2004 Aug; 6(8):456-9. PubMed ID: 15326822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma viscosity and related cardiovascular risk factors in a Spanish Mediterranean population.
    Vayá A; Simó M; Santaolaria M; Carrasco P; Corella D
    Thromb Res; 2007; 120(4):489-95. PubMed ID: 17215030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.